Sequent Scientific inaugurates new state-of-art animal health R&D centre at Mumbai

03 Feb 2020 Evaluate

Sequent Scientific has inaugurated a new state-of-the-art multifaceted and dedicated animal health R&D centre at Ambernath in Mumbai. This unique centre with strong injectable focus has capabilities to develop products of 8 different dosage forms including injectable solutions & suspensions, tablets, oral solutions & suspensions, granules, powders and premixes.

Equipped with the best Lab to Pilot infrastructure, a team of 20 plus research professionals with over 100 plus years of experience, the centre is working on several differentiated products to cater to Alivira’s Global market needs.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×